- Home
- CGEM vs GES Comparison
CGEM vs GES Comparison
Compare CGEM & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- GES
- Stock Information
- Founded
- CGEM 2016
- GES 1981
- Country
- CGEM United States
- GES United States
- Employees
- CGEM N/A
- GES N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- GES Apparel
- Sector
- CGEM Health Care
- GES Consumer Discretionary
- Exchange
- CGEM Nasdaq
- GES Nasdaq
- Market Cap
- CGEM 730.2M
- GES N/A
- IPO Year
- CGEM 2021
- GES 1996
- Fundamental
- Price
- CGEM $12.39
- GES $13.81
- Analyst Decision
- CGEM Strong Buy
- GES Buy
- Analyst Count
- CGEM 7
- GES 6
- Target Price
- CGEM $31.67
- GES $26.00
- AVG Volume (30 Days)
- CGEM 546.1K
- GES 1.1M
- Earning Date
- CGEM 11-07-2024
- GES 11-26-2024
- Dividend Yield
- CGEM N/A
- GES 8.64%
- EPS Growth
- CGEM N/A
- GES N/A
- EPS
- CGEM N/A
- GES 1.77
- Revenue
- CGEM N/A
- GES $2,954,071,000.00
- Revenue This Year
- CGEM N/A
- GES $8.55
- Revenue Next Year
- CGEM N/A
- GES $3.42
- P/E Ratio
- CGEM N/A
- GES $7.82
- Revenue Growth
- CGEM N/A
- GES 9.28
- 52 Week Low
- CGEM $10.00
- GES $13.31
- 52 Week High
- CGEM $30.19
- GES $33.50
- Technical
- Relative Strength Index (RSI)
- CGEM 47.96
- GES 32.81
- Support Level
- CGEM $11.75
- GES $13.31
- Resistance Level
- CGEM $12.95
- GES $14.75
- Average True Range (ATR)
- CGEM 0.76
- GES 0.57
- MACD
- CGEM 0.19
- GES -0.02
- Stochastic Oscillator
- CGEM 77.69
- GES 20.00
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.